|
No.
|
Parent Compound
|
Method
|
Matrix
|
LLOQ
|
|
1
|
1-Methylnicotinamide
|
LC/MS/MS
|
Dog Sodium Citrate Plasma
|
|
|
2
|
1-Methylnicotinamide
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
|
3
|
1-Methylnicotinamide
|
LC/MS/MS
|
Human Urine
|
|
|
4
|
25-Hydroxycholesterol
|
LC/MS/MS
|
Tissue
|
0.1 ng/mL
|
|
5
|
Acetyl-Coenzyme A
|
LC/MS/MS
|
Tumor Tissue
|
100 ng/g
|
|
6
|
ACTH (1-24)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
7
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Monkey Plasma
|
0.05 ng/mL
|
|
8
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
0.05 ng/mL
|
|
9
|
ACTH(1-24)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 pg/mL
|
|
10
|
Adapalene
|
LC/MS/MS
|
K3EDTA Human Plasma
|
10 pg/mL
|
|
11
|
Adenosine
|
LC/MS/MS
|
Plasma
|
|
|
12
|
Agomelatine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
13
|
Aldosterone
|
LC/MS/MS
|
Human Urine
|
0.1 ng/mL
|
|
14
|
Aldosterone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
15
|
Alloprenanolone
|
LC/MS/MS
|
Human Plasma
|
25 pg/mL
|
|
16
|
Almotriptan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
17
|
Aluminum
|
ICP-MS
|
K2EDTA Human Plasma
|
|
|
18
|
Amino Acids
|
LC/MS/MS
|
Cell Culture Media
|
|
|
19
|
Amino Acids
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
20
|
Amphetamine (Chiral)
|
LC/MS/MS Chiral
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
21
|
Angiotensin I
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.14 ng/mL
|
|
22
|
Angiotensin II
|
Immunoassay
|
K2EDTA Human Plasma
|
3.9 pg/mL
|
|
23
|
Anti-IIa
|
|
Human Citric Acid Plasma
|
|
|
24
|
Anti-Xa
|
|
Human Citric Acid Plasma
|
|
|
25
|
Apimostinel
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
26
|
Apremilast
|
LC/MS/MS
|
Human Plasma
|
2 ng/mL
|
|
27
|
Apremilast
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
28
|
Arachidonic Acid
|
LC/MS/MS
|
Cerebrospinal Fluid
|
0.5 ng/mL
|
|
29
|
Arachidonic Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
30
|
Arachidonic Acid, HETE, LTB4
|
LC/MS/MS
|
Cell Culture Media
|
0.025 µM
|
|
31
|
Arachidonoy Glycerol (2AG)
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
|
32
|
Arachidonoyl 1-Glycerol
|
LC/MS/MS
|
Cerebrospinal Fluid
|
10 pg/mL
|
|
33
|
Arachidonoyl 1-Glycerol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
34
|
Arachidonoyl 2-Glycerol
|
LC/MS/MS
|
Cerebrospinal Fluid
|
10 pg/mL
|
|
35
|
Arachidonoyl 2-Glycerol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
36
|
Arachidonoyl Ethanolamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
1 pg/mL
|
|
37
|
Arachidonoyl Ethanolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
38
|
Arachidonoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
|
39
|
Arachidonoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
40
|
Arginase Activity
|
Immunoassay
|
Human Serum
|
0.06 nM
|
|
41
|
Aripiprazole and Dehydroaripiprazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
42
|
Artesunate
|
LC/MS/MS
|
Human Urine
|
|
|
43
|
Ascorbic Acid
|
LC/MS/MS
|
Human Tissue and Lavage Fluid
|
20 ng/mL
|
|
44
|
Atogepant
|
LC/MS/MS
|
Human Plasma
|
|
|
45
|
Atogepant
|
LC/MS/MS
|
Human Urine
|
|
|
46
|
Atorvastatin, 2-Hydroxy Atorvastatin, 4-Hydroxy Atorvastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
47
|
Aztreonam
|
LC/MS/MS
|
Human Plasma
|
0.2 µg/mL
|
|
48
|
Aztreonam
|
LC/MS/MS
|
Human Urine
|
0.2 µg/mL
|
|
49
|
Beclomethasone Dipropionate and its metabolites and Triamcinolone Acetonide
|
|
Dog Matrices
|
|
|
50
|
Betaxolol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
51
|
Bile Acids
|
LC/MS/MS
|
Feces
|
10 ng/mL
|
|
52
|
Bile Acids
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 ng/mL
|
|
53
|
Bimatoprost and its Metabolite
|
LC/MS/MS
|
Human Plasma
|
|
|
54
|
Bimatoprost and its Metabolite
|
LC/MS/MS
|
Mini Pig K2EDTA Blood
|
|
|
55
|
Biotin
|
LC/MS/MS
|
Serum
|
|
|
56
|
Bosentan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
|
57
|
Bosenton (Hydroxy Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
58
|
Brinzolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 µg/mL
|
|
59
|
Bromide
|
ICP-MS
|
Na Heparin Human Plasma
|
0.5 µg/mL
|
|
60
|
Budesonide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 pg/mL
|
|
61
|
Bupremorphine and Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
0.2 ng/mL
|
|
62
|
Bupremorphine and Norbuprenorphine and Naloxone
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
|
|
63
|
Buprenorphine
|
LC/MS/MS
|
Human Urine
|
20 pg/mL
|
|
64
|
Buprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
20 pg/mL
|
|
65
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
Human Urine
|
0.5 pg/mL
|
|
66
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
0.5 pg/mL
|
|
67
|
Buprenorphine Hemiadipate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
|
68
|
C4(7α-hydroxy-4-cholesten-3-one)
|
LC/MS/MS
|
Human Serum
|
|
|
69
|
C4(7α-hydroxy-4-cholesten-3-one)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
70
|
Caffeine
|
LC/MS/MS
|
Human Serum
|
0.05 µg/mL
|
|
71
|
Caffeine
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
72
|
Caffeine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
|
73
|
Calcium
|
ICP/MS
|
Human Serum
|
10 µg/mL
|
|
74
|
Carbamazepine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 µg/mL
|
|
75
|
Carbamazepine (10,11-Epoxide Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.025 µg/mL
|
|
76
|
Carbocysteine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
30 ng/mL
|
|
77
|
Cariprazine and Metabolics
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
78
|
Cariprazine and Metabolics
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
|
79
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
|
K2EDTA Dog Plasma
|
|
|
80
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
81
|
Cariprazine, Desmethyl Cariprazine and Didesmethyl Cariprazine
|
|
K2EDTA Rat Plasma
|
|
|
82
|
Catecholamine
|
LC/MS/MS
|
Human Plasma
|
10 pg/mL
|
|
83
|
Cebranopadol and Metabolites
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
|
84
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.25 μg/ml
|
|
85
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Urine
|
15 & 45 μg/mL
|
|
86
|
Cefiderocol
|
LC/MS/MS
|
Human BAL
|
0.005 µg/mL
|
|
87
|
Cefiderocol
|
LC/MS/MS
|
Human Plasma
|
0.1 µg/mL
|
|
88
|
Cefiderocol
|
LC/MS/MS
|
Dialysate
|
0.2 µg/mL
|
|
89
|
Cefiderocol
|
LC/MS/MS
|
Bovine Plasma
|
0.2 µg/mL
|
|
90
|
Ceftaroline
|
|
Human Plasma & Serum
|
|
|
91
|
Ceftaroline and Metablites
|
LC/MS/MS
|
Human Na2EDTA/NaF Plasma
|
|
|
92
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
Human Urine
|
0.5 µg/mL
|
|
93
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
94
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Cell Culture Medium
|
|
|
95
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Human Sputum
|
|
|
96
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
NaF/KOx Human Plasma
|
|
|
97
|
Cenicriviroc
|
LC/MS/MS
|
M-I, M-II protein binding
|
|
|
98
|
cGAMP
|
LC/MS/MS
|
Human Plasma
|
10 ng/mL
|
|
99
|
Chlorogenic Acid
|
HPLC/UV
|
K2EDTA Human Plasma
|
|
|
100
|
Chlorpheniramine (Chiral)
|
LC/MS/MS Chiral
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
101
|
Chlorpromazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
102
|
Citalopram
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
103
|
Citalopram (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
104
|
Clarithromycin
|
LC/MS/MS
|
Human Plasma
|
10 ng/mL
|
|
105
|
Clarithromycin
|
LC/MS/MS
|
Human BAL
|
1 ng/mL
|
|
106
|
Colistin
|
|
Cell Media
|
|
|
107
|
Colistin
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
|
108
|
Colistin
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
|
109
|
Colistin
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
|
110
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
|
111
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
|
112
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
|
113
|
Cortisol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
|
114
|
Dalbavancin
|
LC/MS/MS
|
Cell Medium
|
|
|
115
|
Dalbavancin
|
LC/MS/MS
|
Human Plasma
|
|
|
116
|
Dalbavancin
|
|
Rabbit Serum
|
|
|
117
|
Dapsone, N-acetyl Dapsone and N-hydroxy Dapsone
|
LC/MS/MS
|
K3EDTA Human Plasma with Ascorbic Acid
|
|
|
118
|
Dapsone, N-acetyl Dapsone and N-hydroxylamine Dapsone
|
LC/MS/MS
|
Human Plasma
|
|
|
119
|
Delafloxacin
|
LC/MS/MS
|
Human BAL
|
0.1 ng/mL
|
|
120
|
DHA-Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
121
|
Digoxin
|
LC/MS/MS
|
Human Urine
|
1 ng/mL
|
|
122
|
Digoxin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
|
123
|
Dimethyl Arginine
|
LC/MS/MS
|
Human Serum
|
10 ng/mL
|
|
124
|
Diphenylhdramine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
|
125
|
Docohexaenoic Acid
|
LC/MS/MS
|
Cerebrospinal Fluid
|
0.5 ng/mL
|
|
126
|
Docohexaenoic Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
127
|
Donepezil and Memantine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
128
|
Donepezil and Metabolites
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
|
129
|
Dopamine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
130
|
Doripenem
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.1μg/ml
|
|
131
|
Dronedarone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
132
|
Dronedarone (Desbutyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
133
|
Drug Antibody Conjugate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 nM
|
|
134
|
Dulaglutide
|
LC/MS/MS
|
Monkey Plasma
|
|
|
135
|
Duloxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
136
|
Efavirenz, Emtricitabine and Tenofovir
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
137
|
Eluxadoline
|
LC/MS/MS
|
Human Protein Binding
|
|
|
138
|
Eluxadoline
|
LC/MS/MS
|
Human Urine
|
|
|
139
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human DBS
|
|
|
140
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human Dried Blood
|
0.1 ng/mL
|
|
141
|
Eluxadoline
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
142
|
Entecavir
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
143
|
Epinephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
144
|
Epinephrine
|
LC/MS/MS
|
Rabbit Plasma
|
|
|
145
|
Ethanolamides
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
146
|
Factor Xa
|
Chromogenic
|
Human Serum
|
0.1 IU
|
|
147
|
Fatty Acid Ethanolamides
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
148
|
Febtanyl
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
|
149
|
Febuxastat
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
150
|
FGF19
|
ELISA
|
K2EDTA Human Plasma
|
|
|
151
|
Flecainide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
152
|
Fluoride
|
IC/ICP/MS
|
Human Serum
|
10 ng/mL
|
|
153
|
Fluoride
|
IC/ICP/MS
|
Rat Serum
|
|
|
154
|
Flupirtine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
|
155
|
Fluticasone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
156
|
Fluticasone Propionate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
|
157
|
Fluticasone Propionate
|
LC/MS/MS
|
Swab
|
|
|
158
|
Formeterol
|
LC/MS/MS
|
NaF/K2C2O4 Human Plasma
|
0.4 pg/mL
|
|
159
|
Fosfomycin
|
LC/MS/MS
|
Human Urine
|
|
|
160
|
Fosfomycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
161
|
Free T3 and T4
|
Chemiluminescent immunoassay
|
Human Serum
|
|
|
162
|
Gamma Hydroxy Butyric Acid (GHB) and Gamma Amino Butyric Acid (GABA)
|
LC/MS/MS
|
Plasma
|
|
|
163
|
GDP Fucose
|
LC/MS/MS
|
Cell Culture Media
|
5 ng/mL
|
|
164
|
Glutarate, 2-Hydroxy
|
LC/MS/MS
|
Cell Culture Media
|
2.5 ng/mL
|
|
165
|
GRT6005 and GRT6006
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
166
|
HETE
|
LC/MS/MS
|
Human Plasma
|
100 pg/mL
|
|
167
|
Histamine Panel
|
LC/MS/MS
|
Feces
|
|
|
168
|
HTL0018318 and HTL0026803
|
LC/MS/MS
|
K3EDTA Human Plasma
|
0.5 ng/mL
|
|
169
|
Hydromorphone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
170
|
Hydroxybutyric Acid
|
LC/MS/MS
|
Human Urine
|
0.25 µg/mL
|
|
171
|
Idebenone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
172
|
Idebenone, Total
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
173
|
Indole
|
LC/MS/MS
|
Rat Urine
|
|
|
174
|
Inositol
|
LC/MS/MS
|
Human Serum
|
1 µg/mL
|
|
175
|
Iodine
|
ICP-MS
|
Media
|
|
|
176
|
Iron Sucrose
|
ICP-MS
|
Human Serum
|
1 ng/mL
|
|
177
|
Isosorbide-5-Mononitrate
|
LC/MS/MS
|
Blood, Urine, liver
|
|
|
178
|
Ivabradine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.01 ng/mL
|
|
179
|
Ivermectin B1a
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.4 ng/mL
|
|
180
|
Ivermectin B1b
|
LC/MS/MS
|
K2EDTA Human Plasma
|
40 pg/mL
|
|
181
|
Ketamine and Norketamine
|
LC/MS/MS
|
Human Plasma
|
1 ng/mL
|
|
182
|
Ketoconazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 µg/mL
|
|
183
|
Ketoprofen
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 ng/mL
|
|
184
|
Ketorolac
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
185
|
Kynurenines
|
LC/MS/MS
|
Human Plasma
|
1 ng/mL
|
|
186
|
Kynurenines
|
LC/MS/MS
|
Plasma
|
|
|
187
|
Lactic + Succinic Acid
|
LC/MS
|
Formulations
|
|
|
188
|
L-Arginine
|
LC/MS/MS
|
Heparinized Human Plasma
|
1 µg/mL
|
|
189
|
Latanoprost and Latanoprost Free Acid
|
LC/MS/MS
|
NaF/KOx Human Plasma
|
|
|
190
|
Levofloxacin
|
LC/MS/MS
|
BAL
|
|
|
191
|
Levofloxacin
|
LC/MS/MS
|
BAL AM Pellet
|
|
|
192
|
Levomilnacipran
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
193
|
Levothyroxine (Free T4)
|
Immunoassay
|
Human Serum
|
0.3 ng/mL
|
|
194
|
Levothyroxine (Total T4)
|
LC/MS/MS
|
Human Serum
|
10 ng/mL
|
|
195
|
Linaclotide and MM-419447
|
LC/MS/MS
|
Human Breast Milk
|
|
|
196
|
Linagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
197
|
Liothyronine (Free T3)
|
Immunoassay
|
Human Serum
|
1 pg/mL
|
|
198
|
Liothyronine (Total T3)
|
LC/MS/MS
|
Human Serum
|
0.1 ng/mL
|
|
199
|
Lipoic Acid
|
LC/MS/MS
|
Tissue
|
0.1 ng/mL
|
|
200
|
Lornoxicam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
|
201
|
Lovastatin , Lovastatin Hydroxy Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
202
|
L-Threonate
|
LC/MS/MS
|
Human Plasma
|
|
|
203
|
Lurasidone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
204
|
Lysophosphatidyl acid
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
10 nM
|
|
205
|
Lysophosphatidylcholine
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
10 nM
|
|
206
|
Malonyl Coenzyme A
|
LC/MS/MS
|
Tissue
|
10 ng/g
|
|
207
|
Melatonin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 pg/mL
|
|
208
|
Melatonin and Theanine
|
LC/MS/MS
|
Human Plasma
|
|
|
209
|
Mercaptopurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
210
|
Methotrexate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
211
|
Methylene Blue
|
LC/MS/MS
|
Mouse Plasma
|
|
|
212
|
MethylHistamine
|
LC/MS/MS
|
Human Plasma
|
0.1 ng/mL
|
|
213
|
Methylphenidate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
|
214
|
Methylphenidate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.1 ng/mL
|
|
215
|
Mevalonic Acid
|
LC/MS/MS
|
Human Urine
|
5 ng/mL
|
|
216
|
Midazolam and 1-hydroxymidazolam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL
|
|
217
|
Mometasone Furoate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
|
218
|
Morphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
219
|
Morphine Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 ng/mL
|
|
220
|
Moxifloxocin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
221
|
NAD+
|
LC/MS/MS
|
Human Red Blood Cell
|
|
|
222
|
NAD+
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
|
223
|
NAD+ and Metabolites
|
LC/MS/MS
|
Human Whole Blood
|
|
|
224
|
NAD+ and Metabolites
|
LC/MS/MS
|
Rat Whole Blood
|
|
|
225
|
Nafithromycin
|
LC/MS/MS
|
Human Plasma
|
|
|
226
|
Nafithromycin and N-desmethyl-Nafithromycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
227
|
Naloxone
|
LC/MS/MS
|
Human Urine
|
5 pg/mL
|
|
228
|
Naloxone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 pg/mL
|
|
229
|
Naloxone
|
LC/MS/MS
|
K3EDTA Human Plasma
|
2 pg/mL
|
|
230
|
Naloxone
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
2 pg/mL
|
|
231
|
Naloxone, Buprenorphine and Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
232
|
Naloxone-3-Glucuronide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 pg/mL
|
|
233
|
Nebivolol, Chiral
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
234
|
Nebivolol, Total
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
235
|
Neurosteroids
|
LC/MS/MS
|
Human Plasma
|
|
|
236
|
Nicotinamide
|
LC/MS/MS
|
Human Sodium Citrate Plasma
|
|
|
237
|
Norbuprenorphine
|
LC/MS/MS
|
Human Urine
|
20 pg/mL
|
|
238
|
Norbuprenorphine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
20 pg/mL
|
|
239
|
Norepinephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
240
|
NR
|
LC/MS/MS
|
Human Whole Blood
|
|
|
241
|
NRX-2922
|
LC/MS/MS
|
Human CSF
|
|
|
242
|
NRX-2922
|
LC/MS/MS
|
Human Urine
|
|
|
243
|
NRX-2922
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
244
|
NRX-2922
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
|
245
|
NRX-2922
|
LC/MS/MS
|
Rat Brain
|
|
|
246
|
NRX-2922
|
LC/MS/MS
|
Rat CSF
|
|
|
247
|
Nucleotides
|
LC/MS/MS
|
Cell Culture Media
|
5 ng/mL
|
|
248
|
Nucleotides
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
|
249
|
Oleoyl Ethanolamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
5 pg/mL
|
|
250
|
Oleoyl Ethanolamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
|
251
|
Oleoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
|
252
|
Oleoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
253
|
Oligonucleotide
|
|
|
|
|
254
|
Omadacycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
|
255
|
Omadacycline
|
HPLC
|
Dosing Solution
|
|
|
256
|
Omadacycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
|
257
|
Omadacycline
|
LC/MS/MS
|
Rat Heparin Plasma
|
|
|
258
|
Omadacycline
|
LC/MS/MS
|
Rat Plasma
|
|
|
259
|
Oxycodone
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
260
|
Oxymetazoline Impurity A
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
|
|
261
|
Palmitic Acid
|
LC/MS/MS
|
Tumor Tissue
|
100 ng/g
|
|
262
|
Palmitoyl Ethanoamide
|
LC/MS/MS
|
Cerebrospinal Fluid
|
5 pg/mL
|
|
263
|
Palmitoyl Ethanoamide
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.25 ng/mL
|
|
264
|
Palmitoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
|
265
|
Palmitoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
266
|
Paroxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
267
|
Peptide A6
|
LC/MS/MS
|
Swine Plasma
|
|
|
268
|
Phenylephrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
10 pg/mL
|
|
269
|
Picolinic Acid
|
|
Plasma
|
|
|
270
|
Piperacillin, Meropenem, & Tazobactam
|
LC/MS/MS
|
Rabbit Plasma
|
0.1 µg/mL
|
|
271
|
Plasma Renin Activity
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.05 ng/mL/hr
|
|
272
|
Platinum
|
ICP-MS
|
K2EDTA Human Plasma
|
1 µg/mL
|
|
273
|
Poloxamer 124
|
LC/MS/MS
|
Acidified K2EDTA Dog Plasma
|
|
|
274
|
Poloxamer 124
|
LC/MS/MS
|
K2EDTA Dog Plasma
|
1 µg/mL
|
|
275
|
Posaconazole
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
276
|
Potassium
|
ICP-MS
|
Human Urine
|
20 µg/mL
|
|
277
|
Pravastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
278
|
Pregnenolone
|
LC/MS/MS
|
Human Plasma
|
25 pg/mL
|
|
279
|
Pregnenolone Sulfates
|
LC/MS/MS
|
Human Plasma
|
250 pg/mL
|
|
280
|
Propranolol and Mannitol
|
LC/MS/MS
|
Krebs-Ringer Buffer
|
|
|
281
|
Pseudoephedrine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
282
|
Pterostilbene
|
LC/MS/MS
|
Human Serum
|
0.5 ng/mL
|
|
283
|
Pyruvic Acid
|
LC/MS/MS
|
Human Urine
|
0.05 µg/mL
|
|
284
|
Ranolazine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
285
|
Rapastinel
|
LC/MS/MS
|
Human Plasma
|
|
|
286
|
Rapastinel
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
287
|
R-Baclofen and AP
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
288
|
Relamorelin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
289
|
Relamorelin
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
0.25 ng/mL
|
|
290
|
R-Ketorolac and S-Ketorolac
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
5 ng/mL
|
|
291
|
Roflumilast and Roflumilast N-Oxide
|
LC/MS/MS
|
Human Lithium Heparin Plasma
|
0.1 ng/mL
|
|
292
|
Rosuvastatin, N-Desmethyl Rosuvastatin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
293
|
Salmeterol
|
LC/MS/MS
|
K2EDTA Human Plasma
|
2 pg/mL
|
|
294
|
Selenium
|
ICP/MS
|
Human Serum
|
100 ng/mL
|
|
295
|
Sepin-1
|
HPLC-UV
|
Dosing Solution
|
|
|
296
|
Sepin-1
|
LC/MS/MS
|
K2EDTA Rat Blood
|
|
|
297
|
Serotonin
|
LC/MS/MS
|
Various
|
1 ng/mL
|
|
298
|
Sertraline
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
299
|
Sertraline (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
300
|
Short Chain Fatty Acids
|
GC/MS
|
Formulations
|
|
|
301
|
Silcone
|
ICP/MS
|
K2EDTA Human Plasma
|
10 µg/mL
|
|
302
|
Sildenafil and N-Desmethyl Sildenafil
|
LC/MS/MS
|
Sodium Heparin Human Plasma
|
1 ng/mL
|
|
303
|
Silicon
|
ICP-MS
|
K2EDTA Human Plasma
|
|
|
304
|
Silodosin and 2 Metabolites
|
|
Human Lithium Heparin Plasma
|
|
|
305
|
Simvastatin, Simvastatin Hydroxy Acid
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
306
|
Sitagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
307
|
Solifenacin and Metabolites
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
|
|
308
|
Statin
|
LC/MS/MS
|
Mouse Plasma and Mouse Muscle
|
|
|
309
|
Stearoyl Taurine
|
LC/MS/MS
|
Cerebrospinal Fluid
|
100 pg/mL
|
|
310
|
Stearoyl Taurine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
311
|
Sulbactam sodium and EXT2514
|
LC/MS/MS
|
Human BAL
|
2 ng/mL
|
|
312
|
Threonate
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
313
|
Threonic Acid
|
LC/MS/MS
|
Human Plasma
|
0.5 ug/mL
|
|
314
|
Thyrotropin Stimulating Hormone (TSH)
|
Immunoassay
|
Human Serum
|
0.2 µIU/mL
|
|
315
|
Tigecycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
|
316
|
Tigecycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
|
317
|
Tiotropium
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 pg/mL
|
|
318
|
Total T3 and T4
|
Chemiluminescent immunoassay
|
Human Serum
|
|
|
319
|
Total T3 and T4
|
LC/MS/MS
|
Human Serum
|
|
|
320
|
TSH
|
Chemiluminescent immunoassay
|
Human Serum
|
|
|
321
|
Ubrogepant
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
322
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Human Plasma
|
|
|
323
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Human Urine
|
|
|
324
|
Ulipristal Acetate and N-Desmethyl Ulipristal Acetate
|
LC/MS/MS
|
Protein Binding
|
|
|
325
|
Undecylenic Acid
|
LC/MS/MS
|
K2EDTA Mouse Plasma
|
|
|
326
|
Undecylenic Acid
|
LC/MS/MS
|
Mini Pig K2EDTA Plasma
|
|
|
327
|
Urea
|
LC/MS/MS
|
Human BAL
|
|
|
328
|
Urea
|
LC/MS/MS
|
Human Bronchoalveolar Lavage
|
0.2 µg/mL
|
|
329
|
Urea
|
LC/MS/MS
|
Human Plasma
|
|
|
330
|
Urea
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
331
|
Urea
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
332
|
Urea
|
LC/MS/MS
|
KOx/NaF Human Plasma
|
100 µg/mL
|
|
333
|
Urea
|
LC/MS/MS
|
Mice Ball
|
|
|
334
|
Urea
|
LC/MS/MS
|
Mice Plasma
|
|
|
335
|
Urea
|
LC/MS/MS
|
Mouse BAL
|
|
|
336
|
Urea
|
LC/MS/MS
|
Mouse Sodium Heparine Plasma
|
|
|
337
|
Uric Acid
|
LC/MS/MS
|
Human Tissue and Lavage Fluid
|
5 ng/mL
|
|
338
|
Uridine, Uric Acid and cAMP
|
LC/MS/MS
|
Plasma
|
|
|
339
|
Valsartan
|
LC/MS/MS
|
K2EDTA Human Plasma
|
5 ng/mL
|
|
340
|
Venlafaxine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
341
|
Venlafaxine (Desmethyl Metabolite)
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
342
|
Vilazodone
|
|
Human Plasma
|
|
|
343
|
Vilazodone
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
2 ng/mL
|
|
344
|
Vilazodone
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
2 ng/mL
|
|
345
|
Vilazodone (M17 Metabolite)
|
LC/MS/MS
|
K2EDTA Rabbit Plasma
|
1 ng/mL
|
|
346
|
Vilazodone (M17 Metabolite)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
1 ng/mL
|
|
347
|
Vildagliptin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
348
|
Vitamin B6
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 ng/mL
|
|
349
|
Vitamin D2, 1, 25-Dihydroxy
|
LC/MS/MS
|
Human Serum
|
10 pg/mL
|
|
350
|
Vitamin D2, 25-Hydroxy
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
|
351
|
Vitamin D3
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.5 ng/mL
|
|
352
|
Vitamin D3, 1, 25-Dihydroxy
|
LC/MS/MS
|
Human Serum
|
10 pg/mL
|
|
353
|
Vitamin D3, 25-Hydroxy
|
LC/MS/MS
|
Human Serum
|
5 ng/mL
|
|
354
|
Vitamin D3, 25-Hydroxy
|
LC/MS/MS
|
K2EDTA Human Plasma
|
1 ng/mL
|
|
355
|
Vortioxetine
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
356
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL
|
|
|
357
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL AM Pellet and BAL ELF
|
|
|
358
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
359
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Urine
|
|
Keystone Bioanalytical